The University of Birmingham has received £2.2m in government funding to improve the treatment, causes and symptoms of so-called Long COVID in non-hospitalised patients.
Posted 14 April 2021 Over-80s show similar antibody responses following single vaccination with either Pfizer or AstraZeneca vaccine – but cellular responses are enhanced after AstraZeneca vaccine People aged over 80 receiving a single dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination, research led by the University of Birmingham establishes.
Posted 12 April 2021 COVID-19 lateral flow testing survey is launched for the city of Birmingham The University of Birmingham and Birmingham City Council have launched a research project to improve people's experiences of Lateral Flow Testing for COVID-19 in Birmingham.
Posted 01 April 2021 Dual dose of the Pfizer COVID-19 vaccine elicits strong antibody immune responses in older people A University of Birmingham-led study has found that 98% of people aged 80 or over who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response.